The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Matthew J. Bott(Memorial Sloan Kettering Cancer Center), Marie Brevet(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center), Shigeki Shimizu(Memorial Sloan Kettering Cancer Center), Tatsuo Ito(Memorial Sloan Kettering Cancer Center), Lu Wang(Memorial Sloan Kettering Cancer Center), Jenette Creaney(University of Western Australia), Richard Lake(Sir Charles Gairdner Hospital), Maureen F. Zakowski(Memorial Sloan Kettering Cancer Center), Boris Reva(Memorial Sloan Kettering Cancer Center), Chris Sander(Memorial Sloan Kettering Cancer Center), Robert Delsite(Memorial Sloan Kettering Cancer Center), Simon N. Powell(Memorial Sloan Kettering Cancer Center), Qin Zhou(Memorial Sloan Kettering Cancer Center), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Adam B. Olshen(Memorial Sloan Kettering Cancer Center), Valerie W. Rusch(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center)
Nature Genetics
June 5, 2011
10.1038/ng.855
Cited by 730

Abstract

Related Papers

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Gordon K. Smyth|Statistical Applications in Genetics and Molecular Biology|2004|12k
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger E. McLendon|Nature|2008|7.8k
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al.|Nature|2005|6.7k
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Mathew E. Sowa, Eric J. Bennett, Steven P. Gygi et al.|Cell|2009|1.6k
Frequent Mutation of <i>BAP1</i> in Metastasizing Uveal Melanomas
J. William Harbour, Michael D. Onken, Elisha Roberson et al.|Science|2010|1.5k